Jiangsu Fengshan Biochem Gears Up for Strategic Expansion in Selective Herbicide Intermediates and Active Ingredients

In a bold move to solidify its position in China’s competitive agrochemical landscape, Jiangsu Fengshan Biochemical Technology Co., Ltd. has unveiled plans for a major technical upgrade and capacity expansion project centered on two high-value selective herbicides: quizalofop-p-ethyl and triclopyr esters. The project, now undergoing pre-approval public disclosure, signals Fengshan’s deepening vertical integration and commitment to capturing growing demand for precision weed control in both agricultural and non-crop settings.

At the heart of the RMB 36 million investment—of which RMB 11.5 million is allocated to environmental safeguards—is a multi-pronged expansion within the company’s existing facility at the Dafeng Port Petrochemical & New Materials Industrial Park. The six-month initiative will:

• Produce 900 tons/year of 2,6-dichloroquinoxaline, a critical intermediate exclusively for Fengshan’s own 1,700-ton/year quizalofop-p-ethyl production line—ensuring supply security and cost control;
• Upgrade the 432 workshop to maintain 1,000 tons/year of triclopyr butoxyethyl ester (98%);
• Convert part of triclopyr acid capacity into potassium salt form, reducing free acid output from 1,000 to 557.2 tons/year while enhancing water solubility for formulation flexibility;
• Most significantly, expand the 433 workshop’s triclopyr butoxyethyl ester capacity from 3,000 to 5,000 tons/year—a 67% increase—without altering core synthesis processes, leveraging existing infrastructure for rapid scale-up.

This expansion is far from speculative. Quizalofop-p-ethyl, an aryloxyphenoxypropionate (AOPP) herbicide, is a cornerstone solution for broadleaf crops like soybeans, cotton, peanuts, and oilseed rape, where it selectively eradicates grassy weeds through systemic inhibition of fatty acid biosynthesis. With global resistance management strategies increasingly favoring mode-of-action diversification, demand for such ACCase inhibitors remains robust.

Meanwhile, triclopyr-based products—including both the butoxyethyl ester (trade name: Garlon® analog) and the newly emphasized potassium salt—serve a dual market: forestry, rangeland, and non-crop areas battling invasive broadleaf shrubs and woody species, as well as cereal fields (wheat, corn, sorghum) needing safe broadleaf weed control. Triclopyr’s unique mechanism—disrupting nucleic acid metabolism and causing uncontrolled meristematic growth—makes it irreplaceable in tough brush management scenarios.

Critically, all intermediates produced, including 2,6-dichloroquinoxaline, will remain captive—never sold externally—reinforcing Fengshan’s strategy of “closed-loop” production to mitigate raw material volatility and protect proprietary process know-how.

The project also underscores Fengshan’s disciplined approach to sustainability: wastewater will be treated at the existing on-site facility, and off-gases routed through established abatement systems, keeping environmental impact tightly controlled despite expanded output.

As a wholly owned subsidiary of Jiangsu Fengshan Group—a Shanghai Stock Exchange-listed (603810), state-designated pesticide manufacturer since 1988—Fengshan Biochem embodies the parent company’s evolution from commodity producer to technology-driven specialty agrochemical player. By anchoring key intermediates and scaling high-margin actives like triclopyr, the group is positioning itself not just for volume, but for resilience, differentiation, and downstream formulation leadership.

In an era where regulatory scrutiny, supply chain fragility, and resistance management are reshaping global herbicide markets, Fengshan’s latest move reveals a clear playbook: control your chemistry, master your molecules, and grow where others cannot easily follow.